Michel Lecendreux Selected Research

Narcolepsy

1/2022	Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patients.
12/2021	New 2013 incidence peak in childhood narcolepsy: more than vaccination?
1/2020	Pharmacokinetics of pitolisant in children and adolescents with narcolepsy.
1/2018	Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.
6/2017	Mazindol: a risk factor for pulmonary arterial hypertension?
3/2017	Intravenous Immunoglobulin Therapy in Pediatric Narcolepsy: A Nonrandomized, Open-Label, Controlled, Longitudinal Observational Study.
1/2017	Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells.
3/2016	Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity.
8/2015	Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms in Pediatric Narcolepsy: A Cross-Sectional Study.
6/2015	Impact of cytokine in type 1 narcolepsy: Role of pandemic H1N1 vaccination ?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michel Lecendreux Research Topics

Disease

25	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019 - 12/2004
22	Narcolepsy 01/2022 - 12/2003
11	Cataplexy 01/2022 - 06/2011
8	Disorders of Excessive Somnolence (Hypersomnia) 12/2021 - 01/2013
3	Headache (Headaches) 01/2018 - 06/2011
3	Restless Legs Syndrome (Restless Legs) 01/2008 - 05/2005
2	Nasopharyngitis 01/2018 - 09/2013
2	Nausea 01/2018 - 09/2013
2	Sleepiness 01/2013 - 06/2011
2	Iron Deficiencies 10/2012 - 01/2008
1	Parasomnias (Parasomnia) 01/2022
1	Apnea 10/2021
1	Body Weight (Weight, Body) 01/2020
1	Oppositional Defiant Disorder 01/2019
1	Conduct Disorder (Conduct Disorders) 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2018
1	Enuresis 01/2018
1	Vomiting 01/2018
1	Dizziness (Lightheadedness) 01/2018
1	Pulmonary Arterial Hypertension 06/2017
1	Anorexia 09/2013
1	Sleep Initiation and Maintenance Disorders (Insomnia) 09/2013
1	Human Influenza (Influenza) 08/2013
1	Obesity 01/2013
1	Idiopathic Hypersomnia 06/2011
1	Sleep Wake Disorders 09/2010
1	Uveitis 03/2010
1	Dyskinesias (Dyskinesia) 07/2009
1	Sleep-Wake Transition Disorders (Sleep Talking) 07/2009
1	Bulimia (Binge Eating) 11/2008
1	Tourette Syndrome (Tourette's Syndrome) 01/2008
1	Weight Loss (Weight Reduction) 01/2008

Drug/Important Bio-Agent (IBA)

10	IronIBA 01/2019 - 12/2004
7	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 01/2022 - 01/2010
7	Methylphenidate (Ritalin)FDA LinkGeneric 12/2021 - 05/2005
7	Lisdexamfetamine Dimesylate FDA Link 12/2014 - 09/2013
6	Modafinil (Provigil)FDA Link 12/2021 - 06/2011
6	OrexinsIBA 01/2017 - 11/2008
6	Ferritins (Ferritin)IBA 10/2012 - 12/2004
4	Amphetamine (Amfetamine)FDA LinkGeneric 12/2021 - 01/2013
4	Mazindol (Mazanor)FDA Link 06/2017 - 01/2008
3	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2021
3	pitolisantIBA 12/2021 - 01/2020
3	Pharmaceutical PreparationsIBA 01/2018 - 01/2013
3	ProdrugsIBA 12/2014 - 10/2013
2	Clomipramine (Anafranil)FDA LinkGeneric 12/2021 - 01/2021
2	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 12/2021 - 01/2021
2	HLA-DQB1 antigen (HLA DQB1)IBA 12/2021 - 01/2014
2	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 12/2021 - 01/2021
2	solriamfetolIBA 12/2021 - 01/2021
2	Wakefulness-Promoting AgentsIBA 01/2018 - 01/2008
2	Appetite Depressants (Anorectics)IBA 06/2017 - 01/2013
2	Intravenous Immunoglobulins (IVIG)FDA Link 03/2017 - 12/2003
2	Epidermal Growth Factor (EGF)IBA 06/2015 - 03/2014
2	VaccinesIBA 06/2015 - 08/2013
2	CytokinesIBA 06/2015 - 03/2014
2	Dopamine (Intropin)FDA LinkGeneric 01/2008 - 08/2005
2	ropinirole (Requip)FDA LinkGeneric 08/2005 - 05/2005
1	Muscarinic AntagonistsIBA 10/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2020
1	SolutionsIBA 01/2018
1	HLA-A Antigens (HLA-A)IBA 03/2016
1	HLA-DPB1 antigen (HLA DPB1)IBA 03/2016
1	ChemokinesIBA 06/2015
1	Interleukin-12 (IL 12)IBA 06/2015
1	InterferonsIBA 06/2015
1	Influenza Vaccines (Influenza Vaccine)FDA Link 06/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2015
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 06/2015
1	Biomarkers (Surrogate Marker)IBA 06/2015
1	Interleukin-8 (Interleukin 8)IBA 03/2014
1	Interleukin-2 (IL2)IBA 03/2014
1	Interleukin-4 (Interleukin 4)IBA 03/2014
1	Transcription Factors (Transcription Factor)IBA 10/2013
1	N 30IBA 08/2013
1	Nonesterified Fatty Acids (NEFA)IBA 03/2013
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2013
1	Cathepsin HIBA 01/2013
1	OX40 LigandIBA 01/2013
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2010
1	HLA-DRB1 Chains (HLA DRB1)IBA 09/2010
1	AutoantigensIBA 03/2010
1	AutoantibodiesIBA 03/2010
1	ferrous sulfate FDA Link 01/2008
1	CatecholaminesIBA 01/2008
1	Carbidopa (Lodosyn)FDA LinkGeneric 08/2005
1	Dopamine Agents (Dopaminergic Agents)IBA 08/2005
1	Levodopa (L Dopa)FDA LinkGeneric 08/2005
1	Pergolide (Permax)FDA Link 08/2005
1	Dopamine Agonists (Dopamine Agonist)IBA 05/2005

Therapy/Procedure

2	Therapeutics 03/2017 - 02/2014
1	Combined Modality Therapy 01/2018
1	Cognitive Training 03/2013
1	Neurofeedback 03/2013